PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

ASO International, Inc.

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from ASO International, Inc.'s yearly results (2022–2026), compared with Healthcare companies in Japan. Tap ? on any ratio for what it means.

What stands out

  • Self-Funding Ratio: Over the last 3 years its own operating cash covered its investment spending (capex) 7.1 times. Higher than 95% of Healthcare companies in Japan.

Where ¥100 of sales goes

¥83Operating costs¥0.0Interest¥12Net profit¥5.6Paid as dividends

Latest year (Jun 2026). Taxes and other income are not shown, so the parts need not add up to 100.

Cash quality

Profit Cash Ratio

¥92

Over the last 3 years, every ¥100 of reported profit came with ¥92 of operating cash.

Lower than 80% of Healthcare companies in Japan.

Self-Funding Ratio

7.1×

Over the last 3 years its own operating cash covered its investment spending (capex) 7.1 times.

Higher than 95% of Healthcare companies in Japan.

Cash Locked Ratio

¥10

For every ¥100 of sales, ¥10 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ¥8 tied up three years earlier.

Less money tied up than 58% of Healthcare companies in Japan.

Growth quality

Steadiness Ratio

3/3 · 2/3

Sales grew in 3 of the last 3 years; profit grew in 2 of 3.

Steadier than 71% of Healthcare companies in Japan.

Growth Efficiency Ratio

¥16

Sales grew 34% in 3 years; of every extra ¥100 of sales, ¥16 became extra profit.

Higher than 69% of Healthcare companies in Japan.

Asset Productivity Ratio

+34% / +71%

In 3 years sales changed by +34% while total assets changed by +71%. Assets grew faster than sales.

Balance-sheet strength

Debt Due Cover Ratio

—

Data incomplete

Cash Cushion Ratio

—

Data incomplete

Tangible Assets Ratio

99%

Of every ¥100 the company owns, ¥99 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.

More tangible than 75% of Healthcare companies in Japan.

Tangible Net Worth Ratio

99%

Of every ¥100 of net worth, ¥99 is tangible; the rest is goodwill and other intangibles, often from buying other companies.

More tangible than 79% of Healthcare companies in Japan.

Shareholders

Shareholder Slice Ratio

+2%

Share count rose 2% in 3 years, so each share's slice of the company became smaller. Dividends paid equalled 36% of profit over the same period.

Bigger rise in share count than 66% of Healthcare companies in Japan.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (11)

ASO International, Inc. owes ¥0.13 for every ¥1 it owns.

Compared with Healthcare companies in Japan · latest annual results Jun 2026.

P/E ratio

15.3

Investors pay ¥15.3 for every ¥1 of ASO International, Inc.'s yearly profit, lower than 55% of Healthcare companies in Japan.

P/B ratio

2.42

The share price is 2.42 times ASO International, Inc.'s book value per share, higher than 72% of Healthcare companies in Japan.

Market cap

¥7.8 B

The total market value of all of ASO International, Inc.'s shares at today's price (share price × number of shares), smaller than 66% of Healthcare companies in Japan. PosiCap size class: Micro Cap.

Net worth (book value)

¥3.2 B

What ASO International, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).

Book value per share

¥329.01

Net worth divided by the number of shares. The share price of ¥795.00 is 2.4 times this, which is the P/B above.

Return on equity (ROE)

16.8%

ASO International, Inc. earned 16.8% on its shareholders' money over the last year, higher than 85% of Healthcare companies in Japan.

Owes vs Owns

0.13×

ASO International, Inc. owes ¥0.13 for every ¥1 it owns (low), lower than 88% of Healthcare companies in Japan.

Dividend yield

3.53%

ASO International, Inc. pays 3.53% of its share price as dividends a year, higher than 73% of dividend-paying Healthcare companies in Japan.

Profit margin

12.4%

ASO International, Inc. keeps ¥12 of every ¥100 of revenue as net profit.

Cash quality

0.9×

Cash from ASO International, Inc.'s business was 0.9× its reported profit in the year to Jun 2026 — less cash came in than the profit reported.

Interest cover

20670.5×

ASO International, Inc.'s operating profit covered its interest costs 20670.5 times in the year to Jun 2026.

Questions

What is ASO International, Inc.'s P/E ratio?

Investors pay ¥15.3 for every ¥1 of ASO International, Inc.'s yearly profit, lower than 55% of Healthcare companies in Japan.

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For ASO International, Inc.: ¥7.8 B ÷ ¥3.2 B (30 Jun 2026) = 2.4.

What is ASO International, Inc.'s return on equity?

ASO International, Inc. earned 16.8% on its shareholders' money over the last year, higher than 85% of Healthcare companies in Japan.

How much does ASO International, Inc. owe compared with what it owns?

ASO International, Inc. owes ¥0.13 for every ¥1 it owns (low), lower than 88% of Healthcare companies in Japan.

Does ASO International, Inc. pay a dividend?

Yes. ASO International, Inc. pays 3.53% of its share price as dividends a year, higher than 73% of dividend-paying Healthcare companies in Japan.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.